Cargando…
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo
Uveal melanoma (UM) is a lethal intraocular malignancy with an average survival of only 2~8 months in patients with hepatic metastasis. Currently, there is no effective therapy for metastatic UM. Here, we reported that niclosamide, an effective repellence of tapeworm that has been approved for use i...
Autores principales: | Zhou, Jingfeng, Jin, Bei, Jin, Yanli, Liu, Yizhi, Pan, Jingxuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436505/ https://www.ncbi.nlm.nih.gov/pubmed/28529629 http://dx.doi.org/10.7150/thno.17451 |
Ejemplares similares
-
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum
por: Zhou, Jingfeng, et al.
Publicado: (2020) -
Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018) -
Antihelminthic niclosamide modulates dendritic cells activation and function
por: Wu, Chieh-Shan, et al.
Publicado: (2014) -
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016) -
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer
por: Leung, Stephen Wan, et al.
Publicado: (2019)